Vsling device for ventricular repair in heart failure
Part of Heart & circulation clinical trials.
This trial tests a new device called Vsling, which is placed inside the heart to help reshape the main pumping chamber (left ventricle) in people with heart failure. It may improve your heart's strength and reduce symptoms like shortness of breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your heart's pumping ability (ejection fraction) needs to be between 20% and 40%.
- Your heart's main pumping chamber must be enlarged (left ventricle >55 mm in diameter when relaxed).
- You cannot have had any mitral valve surgery or repair in the past.
- You cannot have had a dangerous heart rhythm episode (ventricular tachycardia) in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called Vsling™ that helps reshape the heart's main pumping chamber (left ventricle) in people with heart failure. The goal is to improve heart function and reduce symptoms.
This study tests a new heart implant called the Ventura IASD in people with weakened heart pumping (low ejection fraction). The goal is to see if it helps relieve symptoms and improve quality of life in patients with chronic heart failure.
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
This trial tests a less invasive procedure to reshape the heart in people with heart failure due to a scar or aneurysm. It aims to improve heart function and symptoms.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests a new device to treat a leaking aortic valve in people who already have a left ventricular assist device (LVAD). The goal is to fix the leak without open-heart surgery, which may improve how well the LVAD works and reduce symptoms.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.